Indications
- Benign Prostatic Hypertrophy (BPH) (see Benign Prostatic Hypertrophy, [[Benign Prostatic Hypertrophy]])
Pharmacology
- 5α-Reductase Inhibitor (ARI) (see 5α-Reductase Inhibitors, [[5α-Reductase Inhibitors]])
Administration
- PO:
Adverse Effects
- xxx
References
- xxxx